Sign in

CIK 0001742927

  • Non-accelerated filer
  • Smaller reporting company

REVIVA PHARMACEUTICALS HOLDINGS, INC.

Sign in to watch
Ticker
RVPH
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 408-501-8881
Business address
10080 N WOLFE ROAD, SUITE SW3-200, CUPERTINO, CA, 95014
Former names
Tenzing Acquisition Corp.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-03-18 Bhat Laxminarayan President and CEO Grant or award · Stock Option (right to buy) +109,150 109,150
2026-03-18 Bhat Laxminarayan President and CEO Grant or award · Stock Option (right to buy) +40,925 40,925
2025-02-13 Bhat Laxminarayan President and CEO Grant or award · Stock Option (right to buy) +519,000 519,000
2025-02-13 Bhat Laxminarayan President and CEO Grant or award · Stock Option (right to buy) +181,500 181,500
2024-09-15 Bhat Laxminarayan President and CEO Grant or award · Stock Option (right to buy) +158,451 158,451
2024-09-15 Bhat Laxminarayan President and CEO Grant or award · Stock Option (right to buy) +77,843 77,843
2023-04-25 Bhat Laxminarayan President and CEO Grant or award · Stock Option (right to buy) +443,000 443,000
2023-04-25 Bhat Laxminarayan President and CEO Grant or award · Stock Option (right to buy) +150,000 150,000

Page 1 of 1 · 8 trades